Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)

Jian Teng; Seyedali Hejazi; Lotte Hiddingh; Litia Carvalho; Mark De Gooijer; Hiroaki Wakimoto; Marco Barazas; Marie Tannous; Andrew S. Chi; David P. Noske; Pieter Wesseling; Thomas Wurdinger; Tracy T. Batchelor; Bakhos A. Tannous

doi:10.1093/neuonc/noaa166

Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)

Jian Teng, Seyedali Hejazi, Lotte Hiddingh, Litia Carvalho, Mark De Gooijer, Hiroaki Wakimoto, Marco Barazas, Marie Tannous, Andrew S. Chi, David P. Noske, Pieter Wesseling, Thomas Wurdinger, Tracy T. Batchelor, Bakhos A. Tannous

Research related

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

Samenvatting

The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

Originele taal-2	Engels
Pagina's (van-tot)	1894
Aantal pagina's	1
Tijdschrift	Neuro-Oncology
Volume	22
Nummer van het tijdschrift	12
DOI's	https://doi.org/10.1093/neuonc/noaa166
Status	Gepubliceerd - 1 dec. 2020

Toegang tot document

10.1093/neuonc/noaa166

Vingerafdruk

Duik in de onderzoeksthema's van 'Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)'. Samen vormen ze een unieke vingerafdruk.

Citeer dit

Teng, J., Hejazi, S., Hiddingh, L., Carvalho, L., De Gooijer, M., Wakimoto, H., Barazas, M., Tannous, M., Chi, A. S., Noske, D. P., Wesseling, P., Wurdinger, T., Batchelor, T. T., & Tannous, B. A. (2020). Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198). Neuro-Oncology, 22(12), 1894. https://doi.org/10.1093/neuonc/noaa166

@article{6d80a2a979a94fcfb6900a32a2c1eccf,

title = "Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)",

abstract = "The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).",

author = "Jian Teng and Seyedali Hejazi and Lotte Hiddingh and Litia Carvalho and {De Gooijer}, Mark and Hiroaki Wakimoto and Marco Barazas and Marie Tannous and Chi, {Andrew S.} and Noske, {David P.} and Pieter Wesseling and Thomas Wurdinger and Batchelor, {Tracy T.} and Tannous, {Bakhos A.}",

year = "2020",

month = dec,

day = "1",

doi = "10.1093/neuonc/noaa166",

language = "English",

volume = "22",

pages = "1894",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "12",

}

Teng, J, Hejazi, S, Hiddingh, L, Carvalho, L, De Gooijer, M, Wakimoto, H, Barazas, M, Tannous, M, Chi, AS, Noske, DP, Wesseling, P, Wurdinger, T, Batchelor, TT & Tannous, BA 2020, 'Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)', Neuro-Oncology, vol. 22, nr. 12, blz. 1894. https://doi.org/10.1093/neuonc/noaa166

Erratum: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198). / Teng, Jian; Hejazi, Seyedali; Hiddingh, Lotte et al.
In: Neuro-Oncology, Vol. 22, Nr. 12, 01.12.2020, blz. 1894.

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

TY - JOUR

T1 - Erratum

T2 - Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (Neuro-Oncology 20:5 DOI: 10.1093/neuonc/nox198)

AU - Teng, Jian

AU - Hejazi, Seyedali

AU - Hiddingh, Lotte

AU - Carvalho, Litia

AU - De Gooijer, Mark

AU - Wakimoto, Hiroaki

AU - Barazas, Marco

AU - Tannous, Marie

AU - Chi, Andrew S.

AU - Noske, David P.

AU - Wesseling, Pieter

AU - Wurdinger, Thomas

AU - Batchelor, Tracy T.

AU - Tannous, Bakhos A.

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

AB - The authors wish to correct a mistake in Figure 1, Panel A: the label for cell SNZ308, SNZ308r1, and SNZ308r2 should be LNZ308, LNZ308r1, and LNZ308r2, respectively (Volume 20, Issue 5, doi:10.1093/neuonc/nox198).

UR - http://www.scopus.com/inward/record.url?scp=85098741966&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noaa166

DO - 10.1093/neuonc/noaa166

M3 - Comment/debate

C2 - 33112953

AN - SCOPUS:85098741966

SN - 1522-8517

VL - 22

SP - 1894

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 12

ER -